Levobunolol

CHEMBL1201237 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

291.4 g/mol

LogP

2.4

Phase

4

A non-selective beta-blocker used as an eye drop to lower intraocular pressure in glaucoma and ocular hypertension. It reduces the production of aqueous humor in the eye.

Peso Molecular

291,4000 g/mol

LogP

2,40

TPSA

58,60 Å²

Regra dos 5 de Lipinski

Aprovado

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O

InChI

InChI=1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3/t12-/m0/s1

Molecular Formula

C17H25NO3

HBD / HBA

2 / 4

Ligações Rotacionáveis

6

Átomos Pesados

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A non-selective beta-blocker used as an eye drop to lower intraocular pressure in glaucoma and ocular hypertension. It reduces the production of aqueous humor in the eye.

Yes, Levobunolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201237. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 39468. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Levobunolol no PillFYI

Estrutura

Dados Rápidos

Fórmula: C17H25NO3

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.